Why this pill lowers cholesterol only in some rats
Selective Compensatory Induction of Hepatic HMG-CoA Reductase in Response to Inhibition of Cholesterol Absorption
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A drug called ezetimibe blocks cholesterol from being absorbed in the gut. In sick rats that make little cholesterol themselves, the liver makes more of a key enzyme to compensate, and blood cholesterol drops. But in healthy rats that already make lots of cholesterol, the drug does nothing.
Surprising Findings
Ezetimibe increases HMG-CoA reductase protein without increasing mRNA levels.
It’s counterintuitive that a drug lowering cholesterol would make the liver produce more of its main cholesterol-making enzyme—especially without gene activation. This suggests a hidden, non-genetic compensation mechanism.
Practical Takeaways
If you’re on ezetimibe and not seeing results, your body might be making too much cholesterol naturally—talk to your doctor about testing synthesis markers.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A drug called ezetimibe blocks cholesterol from being absorbed in the gut. In sick rats that make little cholesterol themselves, the liver makes more of a key enzyme to compensate, and blood cholesterol drops. But in healthy rats that already make lots of cholesterol, the drug does nothing.
Surprising Findings
Ezetimibe increases HMG-CoA reductase protein without increasing mRNA levels.
It’s counterintuitive that a drug lowering cholesterol would make the liver produce more of its main cholesterol-making enzyme—especially without gene activation. This suggests a hidden, non-genetic compensation mechanism.
Practical Takeaways
If you’re on ezetimibe and not seeing results, your body might be making too much cholesterol naturally—talk to your doctor about testing synthesis markers.
Publication
Journal
Experimental Biology and Medicine
Year
2006
Authors
G. Ness, Reed C. Holland, D. Lopez
Related Content
Claims (5)
In healthy rats that naturally make a lot of cholesterol in their liver, the drug ezetimibe didn’t lower their blood cholesterol at all.
When diabetic rats ate a high-cholesterol diet and were given a drug called ezetimibe, their blood cholesterol dropped dramatically, and their liver made more of a key cholesterol-making enzyme—not by making more of its instructions, but by using the existing instructions more efficiently.
In rats without thyroid glands that ate a high-cholesterol diet, a drug called ezetimibe lowered their blood cholesterol and brought back their liver’s cholesterol-making enzyme to normal levels, but didn’t change the receptor that clears cholesterol from the blood.
Even though ezetimibe lowered cholesterol and changed a key liver enzyme in diabetic and thyroid-deficient rats, it didn’t change the liver’s cholesterol-cleaning receptors at all.
Ezetimibe works best when the liver isn’t making much cholesterol on its own and the gut is absorbing a lot from food.